Company: BBVXF
Filing Date: 2025-02-27
Form Type: F-4/A
Source: 0001193125-25-037317
Chunk: 188

Company: BANCO BILBAO VIZCAYA ARGENTARIA, S.A.
Filing Date: 2025-02-27
Form: F-4/A
Chunk 188
---
 authorization (equal to 666,788,658 new BBVA shares). The board of directors’ authorization to issue new BBVA shares expires on March 18, 2027. As of the date of this offer to exchange/prospectus, BBVA’s board of directors
has not exercised this authorization.

In addition, at the ordinary general shareholders’ meeting of BBVA, held on March 18,
2022, BBVA’s shareholders delegated to BBVA’s board of directors, for a period of five years, the authority to issue securities convertible into newly issued BBVA shares other than contingent convertible securities (“CoCos”) up
to the maximum overall amount of €6,000,000,000 or its equivalent in any other currency, delegating in turn the power to exclude preemptive subscription rights. However, this power is limited, such that the nominal amount of any share capital
increases resolved or effectively carried out to cover the conversion of convertible issuances that may equally be made with the exclusion of preemptive subscription rights in use of this authority and those capital increases that may be resolved or
carried out with the exclusion of preemptive subscription rights in use of the authority described above may not exceed the nominal maximum overall amount of 10% of BBVA’s share capital as of the date of the authorization (equivalent to
666,788,658 new BBVA shares). The board of directors’ authorization to issue securities convertible into newly-issued BBVA shares other than CoCos expires on March 18, 2027. As of the date of this offer to exchange/prospectus, BBVA’s
board of directors has not exercised this authorization.

Finally, at the ordinary general shareholders’ meeting of BBVA, held on
April 20, 2021, BBVA’s shareholders delegated to BBVA’s board of directors, for a period of five years, the authority to issue securities convertible into newly-issued BBVA shares whose conversion is contingent and which is intended
to meet regulatory requirements for their eligibility as capital instruments, in accordance with the solvency regulations

134

applicable from time to time (CoCos), up to the maximum overall amount of €8,000,000,000 or its equivalent in any other currency. BBVA’s board of directors is authorized to exclude
preemptive rights, in whole or in part, pursuant to the applicable provisions of the Spanish Corporation Law. The board of directors’ authorization to issue securities convertible into newly-issued BBVA shares expires on